AGRI NUTRITION GROUP LTD
SC 13D, 1999-02-18
PHARMACEUTICAL PREPARATIONS
Previous: GEOWORKS /CA/, SC 13G, 1999-02-18
Next: PRICE T ROWE PERSONAL STRATEGY FUNDS INC, N-30D, 1999-02-18





                          SECURITIES AND EXCHANGE COMMISSION
                                Washington, D.C. 20549

                                     SCHEDULE 13D

                       Under the Securities Exchange Act of 1934


                             Agri-Nutrition Group Limited      
                                   (Name of Issuer)

                        Common Stock, Par Value $0.01 Per Share      
                            (Title of Class of Securities)

                                      00849K 10 0                 
                                    (CUSIP Number)

                                Joseph S. Carlin, Esq.
                                  Dyer Ellis & Joseph
                                 Watergate, Suite 1100
                               600 New Hampshire Avenue
                                 Washington, DC 20037
                                    (202) 944-3560                     
(Name, Address and Telephone Number of Persons Authorized to Receive Notices and
                                    Communications)

                                   February 8, 1999               
                (Date of Event which Requires Filing of this Statement)


If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  that is the subject of this  Schedule  13D, and is filing this
schedule because of ss.ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box o.

Note:  Schedules  filed in paper format shall include a signed original and five
copies of the  schedule,  including  all exhibits.  See  ss.240.13d-7  for other
parties to whom copies are to be sent.

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be  "filed"  for the  purpose of  Section  18 of the  Securities  Act of 1934
("Act") or otherwise  subject to the  liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes.)


                                                Page 1 of 15 Pages

<PAGE>



                               SCHEDULE 13D

CUSIP No. 00849K 10 0


      1  NAME OF REPORTING PERSON
         I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

         Durvet/PMR, L.P.
         I.R.S. No. 43 1670982
      2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*             (a) |_|
                                                                       (b) |_|
      3  SEC USE ONLY
      4  SOURCE OF FUNDS*
         OO
      5  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
         PURSUANT TO ITEMS 2(d) OR 2(e)                               |_|
      6  CITIZENSHIP OR PLACE OF ORGANIZATION
         State of Missouri
                               7 SOLE VOTING POWER
                                                             -0-
                      NUMBER OF
                       SHARES
                    BENEFICIALLY
                    OWNED BY EACH
                     REPORTING
                    PERSON WITH

                                                   8  SHARED VOTING POWER
                                                      3,750,324**
                                                   9  SOLE DISPOSITIVE POWER
                                                      1,240,000**
                                                  10  SHARED DISPOSITIVE POWER
                                                      -0-
     11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
         3,750,324**
     12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
         CERTAIN SHARES*                                                |_|
     13  PERCENT OF CLASS REPRESENTED
         BY AMOUNT IN ROW (11)
         37.3%**
     14  TYPE OF REPORTING PERSON*
         PN

                     *SEE INSTRUCTIONS BEFORE FILLING OUT

                 **SEE DESCRIPTION PRESENTED UNDER THE CAPTION
                "ITEM 5. INTEREST IN SECURITIES OF THE ISSUER"

                              Page 2 of 15 Pages

<PAGE>



                                SCHEDULE 13D

CUSIP No. 00849K 10 0


      1  NAME OF REPORTING PERSON
         I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

         W. M. Jones, Jr.
      2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*          (a) |_|
                                                                    (b) |_|
      3  SEC USE ONLY
      4  SOURCE OF FUNDS*
         OO
      5  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
         PURSUANT TO ITEMS 2(d) or 2(e)                                  |_|
      6  CITIZENSHIP OR PLACE OF ORGANIZATION
         United States
                               7 SOLE VOTING POWER
                                                             -0-
                      NUMBER OF
                       SHARES
                    BENEFICIALLY
                    OWNED BY EACH
                     REPORTING
                    PERSON WITH

                                                   8  SHARED VOTING POWER
                                                      3,750,324**
                                                   9  SOLE DISPOSITIVE POWER
                                                      667,107**
                                                  10  SHARED DISPOSITIVE POWER
                                                      -0-
     11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
         3,750,324**
     12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
         CERTAIN SHARES*                                                |_|
     13  PERCENT OF CLASS REPRESENTED
         BY AMOUNT IN ROW (11)
         37.3%**
     14  TYPE OF REPORTING PERSON*
         IN

                             *SEE INSTRUCTIONS BEFORE FILLING OUT!

                         **SEE DESCRIPTION PRESENTED UNDER THE CAPTION
                        "ITEM 5. INTEREST IN SECURITIES OF THE ISSUER"

                                      Page 3 of 15 Pages

<PAGE>



                                   SCHEDULE 13D

CUSIP No. 00849K 10 0


      1  NAME OF REPORTING PERSON
         IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

         Bruce G. Baker
      2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*           (a) |_|
                                                                     (b) |_|
      3  SEC USE ONLY
      4  SOURCE OF FUNDS*
         OO
      5  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
         PURSUANT TO ITEMS 2(d) or 2(e)                                 |_|
      6  CITIZENSHIP OR PLACE OF ORGANIZATION
         United States
                               7 SOLE VOTING POWER
                                                             -0-
                      NUMBER OF
                       SHARES
                    BENEFICIALLY
                    OWNED BY EACH
                     REPORTING
                    PERSON WITH

                                                   8  SHARED VOTING POWER
                                                      3,750,324**
                                                   9  SOLE DISPOSITIVE POWER
                                                      618,291**
                                                  10  SHARED DISPOSITIVE POWER
                                                      -0-
     11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
         3,750,324**
     12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
         CERTAIN SHARES*                                                  |_|
     13  PERCENT OF CLASS REPRESENTED
         BY AMOUNT IN ROW (11)
         37.3%**
     14  TYPE OF REPORTING PERSON*
         IN

                         *SEE INSTRUCTIONS BEFORE FILLING OUT!

                     **SEE DESCRIPTION PRESENTED UNDER THE CAPTION
                    "ITEM 5. INTEREST IN SECURITIES OF THE ISSUER"

                                  Page 4 of 15 Pages

<PAGE>



                                   SCHEDULE 13D

CUSIP No. 00849K 10 0


      1  NAME OF REPORTING PERSON
         I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

         Robert W. Schlutz
      2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*            (a) |_|
                                                                      (b) |_|
      3  SEC USE ONLY
      4  SOURCE OF FUNDS*
         OO
      5  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
         PURSUANT TO ITEMS 2(d) or 2(e)                                |_|
      6  CITIZENSHIP OR PLACE OF ORGANIZATION
         United States
                               7 SOLE VOTING POWER

                      NUMBER OF
                       SHARES
                    BENEFICIALLY
                    OWNED BY EACH
                     REPORTING
                    PERSON WITH

                                                   8  SHARED VOTING POWER
                                                      3,750,324**
                                                   9  SOLE DISPOSITIVE POWER
                                                      485,280**
                                                  10  SHARED DISPOSITIVE POWER

     11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
         3,750,324**
     12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
         CERTAIN SHARES*                                              |_|
     13  PERCENT OF CLASS REPRESENTED
         BY AMOUNT IN ROW (11)
         37.3%**
     14  TYPE OF REPORTING PERSON*
         IN

                     *SEE INSTRUCTIONS BEFORE FILLING OUT!

                 **SEE DESCRIPTION PRESENTED UNDER THE CAPTION
                "ITEM 5. INTEREST IN SECURITIES OF THE ISSUER"

                              Page 5 of 15 Pages

<PAGE>



                                SCHEDULE 13D

CUSIP No. 00849K 10 0


      1  NAME OF REPORTING PERSON
         I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

         Alec L. Poitevint, II
      2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*            (a) |_|
                                                                      (b) |_|
      3  SEC USE ONLY
      4  SOURCE OF FUNDS*
         OO
      5  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
         PURSUANT TO ITEMS 2(d) or 2(e)                              |_|
      6  CITIZENSHIP OR PLACE OF ORGANIZATION
         United States
                               7 SOLE VOTING POWER
                                                             -0-
                      NUMBER OF
                       SHARES
                    BENEFICIALLY
                    OWNED BY EACH
                     REPORTING
                    PERSON WITH

                                                   8  SHARED VOTING POWER
                                                      3,750,324**
                                                   9  SOLE DISPOSITIVE POWER
                                                      408,844**
                                                  10  SHARED DISPOSITIVE POWER
                                                      -0-
     11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
         3,750,324**
     12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
         CERTAIN SHARES*                                                |_|
     13  PERCENT OF CLASS REPRESENTED
         BY AMOUNT IN ROW (11)
         37.3%**
     14  TYPE OF REPORTING PERSON*
         IN

                   *SEE INSTRUCTIONS BEFORE FILLING OUT!

               **SEE DESCRIPTION PRESENTED UNDER THE CAPTION
              "ITEM 5. INTEREST IN SECURITIES OF THE ISSUER"

                            Page 6 of 15 Pages

<PAGE>



                               SCHEDULE 13D

CUSIP No. 00849K 10 0


      1  NAME OF REPORTING PERSON
         I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

         Robert E. Hormann
      2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*             (a) |_|
                                                                       (b) |_|
      3  SEC USE ONLY
      4  SOURCE OF FUNDS*
         OO
      5  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
         PURSUANT TO ITEMS 2(d) or 2(e)                                   |_|
      6  CITIZENSHIP OR PLACE OF ORGANIZATION
         United States
                               7 SOLE VOTING POWER
                                                             -0-
                      NUMBER OF
                       SHARES
                    BENEFICIALLY
                    OWNED BY EACH
                     REPORTING
                    PERSON WITH

                                                   8  SHARED VOTING POWER
                                                      3,750,324**
                                                   9  SOLE DISPOSITIVE POWER
                                                      228,427**
                                                  10  SHARED DISPOSITIVE POWER
                                                      -0-
     11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
         3,750,324**
     12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
         CERTAIN SHARES*                                              |_|
     13  PERCENT OF CLASS REPRESENTED
         BY AMOUNT IN ROW (11)
         37.3%**
     14  TYPE OF REPORTING PERSON*
         IN

                     *SEE INSTRUCTIONS BEFORE FILLING OUT!

                 **SEE DESCRIPTION PRESENTED UNDER THE CAPTION
                "ITEM 5. INTEREST IN SECURITIES OF THE ISSUER"

                              Page 7 of 15 Pages

<PAGE>



                                SCHEDULE 13D

CUSIP No. 00849K 10 0


      1  NAME OF REPORTING PERSON
         I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

         Robert J. Elfanbaum
      2  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*           (a) |_|
                                                                     (b) |_|
      3  SEC USE ONLY
      4  SOURCE OF FUNDS*
         OO
      5  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
         PURSUANT TO ITEMS 2(d) or 2(e)                              |_|
      6  CITIZENSHIP OR PLACE OF ORGANIZATION
         United States
                               7 SOLE VOTING POWER
                                                             -0-
                      NUMBER OF
                       SHARES
                    BENEFICIALLY
                    OWNED BY EACH
                     REPORTING
                    PERSON WITH

                                                   8  SHARED VOTING POWER
                                                      3,750,324**
                                                   9  SOLE DISPOSITIVE POWER
                                                      102,375**
                                                  10  SHARED DISPOSITIVE POWER
                                                      -0-
     11  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
         3,750,324**
     12  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
         CERTAIN SHARES*                                             |_|
     13  PERCENT OF CLASS REPRESENTED
         BY AMOUNT IN ROW (11)
         37.3%**
     14  TYPE OF REPORTING PERSON*
         IN

                       *SEE INSTRUCTIONS BEFORE FILLING OUT!

                   **SEE DESCRIPTION PRESENTED UNDER THE CAPTION
                  "ITEM 5. INTEREST IN SECURITIES OF THE ISSUER"

                                Page 8 of 15 Pages

<PAGE>





ITEM 1.  SECURITY AND ISSUER.

         This Statement  relates to the common stock,  par value $0.01 per share
(the "Common Stock") of  Agri-Nutrition  Group Limited,  a Delaware  corporation
(the "Issuer").

         The  Company's  principal  executive  offices are located at  Riverport
Executive  Center  II,  13801  Riverport  Drive,  Suite 111,  Maryland  Heights,
Missouri 63043.

ITEM 2.  IDENTITY AND BACKGROUND.

        Pursuant to Rule  13d-1(k)(1) of Regulation 13D of the General Rules and
Regulations  under  the  Securities  Exchange  Act of  1934  (the  "Act"),  this
Statement is being filed by (i) Durvet/PMR,  L.P., (ii) W. M. Jones,  Jr., (iii)
Bruce G. Baker, (iv) Robert W. Schlutz,  (v) Alec E. Poitevint,  II, (vi) Robert
E. Hormann and (vii) Robert J. Elfanbaum.  The foregoing  persons and entity are
hereinafter  referred to as the "Reporting  Persons." The Reporting  Persons are
making this single joint filing pursuant to Rule  13d-1(k)(1).  Unless otherwise
indicated,  the business address of each Reporting Person is c/o  Agri-Nutrition
Group Limited,  Riverport Executive Center II, 13801 Riverport Drive, Suite 111,
Maryland Heights, Missouri 63043.

     Durvet/PMR,  L.P. is a Missouri  limited  partnership that was organized to
hold common  stock of the Issuer.  The general  partner of  Durvet/PMR,  L.P. is
Durvet, Inc., a Missouri corporation engaged in animal health product marketing,
warehousing,  and distribution.  The principal  offices of Durvet/PMR,  L.P. and
Durvet, Inc. are located at P.O. Box 279, 100 S.E. Magellan Drive, Blue Springs,
Missouri 64014. The attached Schedule I is a list of the executive  officers and
directors of Durvet, Inc.; each of the named persons is a U.S. citizen.

         W. M. Jones, Jr. is a director of the Issuer and is a U.S. citizen.

     Bruce G. Baker is a director,  president and chief executive officer of the
Issuer and is a U.S. citizen.

     Robert W.  Schlutz is a director  of the  Issuer and  president  of Schlutz
Enterprises, Inc., which owns and operates Kentucky Fried Chicken franchises and
various other business and real estate  development  properties.  Mr.  Schlutz's
business  address is c/o Schlutz  Enterprises,  Inc., Box 269, 14812 "N" Avenue,
Columbus Junction, Iowa 52738. Mr. Schlutz is a U.S. citizen.

     Alec.E.  Poitevint,  II is the  chairman  of the  Issuer and  president  of
Southeastern Minerals,  Inc., a manufacturer and distributor of mineral premixes
and  ingredients  for  animal  feed.  Mr.  Poitevint's  business  address is c/o
Southeastern  Minerals,  Inc.,  P.O.  Box 1866,  1100 Dothan  Road,  Bainbridge,
Georgia 31718. Mr. Poitevint is a U.S. citizen.

     Robert E. Hormann is vice chairman of the Issuer and president and director
of Durvet,  Inc. Mr. Hormann's  business  address is c/o Durvet,  Inc., P.O. Box
279, 100 S.E.  Magellan Drive,  Blue Springs,  Missouri 64014.  Mr. Hormann is a
U.S. citizen.

     Robert J.  Elfanbaum  is the chief  financial  officer of the  Issuer.  Mr.
Elfanbaum is a U.S. citizen.

                                                Page 9 of 15 Pages

<PAGE>



         During the last five years,  none of the  Reporting  Persons or, to the
knowledge of any Reporting Person, any of the persons named in this Item 2 or in
the related Schedules,  has been convicted in a criminal  proceeding  (excluding
traffic  violations  or  similar  misdemeanors)  or has  been a party to a civil
proceeding of a judicial or administrative body of competent jurisdiction and as
a result of such  proceeding  was or is subject to a  judgment,  decree or final
order  enjoining  future  violations of, or prohibiting or mandating  activities
subject  to,  federal or state  securities  laws or finding any  violation  with
respect to such laws.

         The information  with respect to a particular  Reporting Person and its
executive officers,  directors and controlling persons contained herein is given
solely by such Reporting Person and no other Reporting Person has responsibility
for the  accuracy or  completeness  of  information  supplied by such  Reporting
Person.

ITEM 3.  SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

         No cash consideration was paid in connection with the transactions that
require the filing of this amendment.  For a description of these  transactions,
see Item 4 below.

ITEM 4.  PURPOSE OF TRANSACTION.

         The Issuer,  Virbac  S.A.,  a French  corporation  ("VBSA") and Virbac,
Inc., a Delaware  corporation  ("Virbac")  entered into an Agreement and Plan of
Merger  dated as of October 16,  1998 and  amended as of November  20, 1998 (the
"Merger  Agreement").  Pursuant to the Merger  Agreement,  the Reporting Persons
entered into a Stockholders' Agreement dated as of February 8, 1999, pursuant to
which  the  Principal  Stockholders  agreed  (i) to vote all the  shares  of the
Issuer's Common Stock held by them for approval of the Merger  Agreement and the
transactions  contemplated  thereby and (ii) if in a tender offer required to be
made by the merged entity  following the merger,  fewer than 1,000,000 shares of
the Issuer's Common Stock are tendered by the Issuer's  stockholders,  to tender
shares of Common Stock equaling the difference  between 1,000,000 shares and the
amount  actually  tendered.  The foregoing  obligations of each of the Reporting
Persons  who are  directors  or  officers  of the  Issuer  are  subject  to such
directors' and officers'  obligations to faithfully  discharge their duties as a
director or an officer of the Issuer. A copy of the  Stockholders'  Agreement is
filed as Appendix A to this Schedule 13D.

         The  Reporting  Persons  acquired  the  shares  of  Common  Stock as an
investment  and may from time to time  acquire or dispose of  additional  shares
through open market and privately negotiated  transactions depending on existing
market and economic  conditions.  The Reporting  Persons  intend to review their
investment in the Issuer on a continuing  basis and,  depending on the price and
availability  of shares,  subsequent  developments  affecting  the  Issuer,  the
Issuer's  business and prospects,  other  investment and business  opportunities
available to the Reporting Persons, and other factors considered  relevant,  may
decide to increase or decrease the size of their investment in the Issuer.

         Except as  described  in this Item 4 above and in  connection  with the
transactions  contemplated by the Merger Agreement, the Reporting Persons do not
have  either  plans or  proposals  related to or that  would  result in: (i) the
acquisition  by any person of  additional  securities  of the  Company;  (ii) an
extraordinary  corporate  transaction,  such  as  a  merger,  reorganization  or
liquidation,  involving the Company or any of its subsidiaries;  (iii) a sale or
transfer  of a  material  amount of the  assets of the  Company or of any of its
subsidiaries; (iv) any change in the present board of directors or management of
the Company or any of its  subsidiaries,  including  any plans or  proposals  to
change the

                                                Page 10 of 15 Pages

<PAGE>



number or term of directors or to fill any existing  vacancies on the board; (v)
any  material  change in the present  capitalization  or dividend  policy of the
Company;  (vi) any other material change in the Company's  business or corporate
structure;  (vii) any changes in the Company's  charter,  by-laws or instruments
corresponding  thereto  or other  actions  that may impede  the  acquisition  of
control of the Company by any persons; (viii) causing the shares of Common Stock
to be delisted from a national  securities exchange or to cease to be authorized
to be quoted  in an  inter-dealer  quotation  system  of a  registered  national
securities  association;  (ix) any class of  equity  securities  of the  Company
becoming  eligible for termination of registration  pursuant to Section 12(g)(4)
of the Act;  or (x) any action  similar to any of those  enumerated  above.  The
Reporting Persons reserve the right,  either  individually or in any combination
among  themselves or together with one or more of the other  stockholders of the
Company,  to determine in the future to take or cause to be taken one or more of
the foregoing actions.

ITEM 5.  INTEREST IN SECURITIES OF THE COMPANY.

Durvet/PMR, L.P.:

         In  accordance   with  Rule   13d-5(b)(1)  of  the  General  Rules  and
Regulations  under the Act,  Durvet/PMR,  L.P. may be deemed to beneficially own
3,750,324 shares of Common Stock, which constitutes  approximately  37.3% of the
outstanding  shares  of Common  Stock.  Durvet/PMR,  L.P.  has sole  voting  and
dispositive  power with respect to 1,240,000 of the shares of Common Stock;  and
may be deemed to have  shared  voting  power with  respect to  3,750,324  of the
shares of Common  Stock  (constituting  37.3% of the total  voting  power of the
Common Stock) as a result of the Stockholders' Agreement.

W. M. Jones, Jr.:

     In accordance  with Rule  13d-5(b)(1) of the General Rules and  Regulations
under the Act,  W. M. Jones,  Jr. may be deemed to  beneficially  own  3,750,324
shares of Common Stock, which constitutes approximately 37.3% of the outstanding
shares of Common Stock. W. M. Jones,  Jr. has sole voting and dispositive  power
with respect to 667,107 of the shares of Common Stock; and may be deemed to have
shared  voting  power with  respect to  3,750,324  of the shares of Common Stock
(constituting  37.3% of the total voting power of the Common  Stock) as a result
of the Stockholders' Agreement.

Bruce G. Baker:

         In  accordance   with  Rule   13d-5(b)(1)  of  the  General  Rules  and
Regulations  under the Act,  Bruce G.  Baker may be deemed to  beneficially  own
3,750,324 shares of Common Stock, which constitutes  approximately  37.3% of the
outstanding  shares  of  Common  Stock.  Bruce  G.  Baker  has sole  voting  and
dispositive power with respect to 618,291 of the shares of Common Stock; and may
be deemed to have shared voting power with respect to 3,750,324 of the shares of
Common Stock  (constituting 37.3% of the total voting power of the Common Stock)
as a result of the Stockholders' Agreement.

Robert W. Schlutz:

         In  accordance   with  Rule   13d-5(b)(1)  of  the  General  Rules  and
Regulations  under the Act, Robert W. Schlutz may be deemed to beneficially  own
3,750,324 shares of Common Stock, which constitutes  approximately  37.3% of the
outstanding  shares of Common  Stock.  Robert W.  Schlutz  has sole  voting  and
dispositive power with respect to 485,280 of the shares of Common Stock; and may
be deemed to

                                                Page 11 of 15 Pages

<PAGE>



have shared voting power with respect to 3,750,324 of the shares of Common Stock
(constituting  37.3% of the total voting power of the Common  Stock) as a result
of the Stockholders' Agreement.

Alec L. Poitevint, II:

         In  accordance   with  Rule   13d-5(b)(1)  of  the  General  Rules  and
Regulations  under the Act, Alec L. Poitevint,  II may be deemed to beneficially
own 3,750,324 shares of Common Stock, which constitutes  approximately  37.3% of
the outstanding  shares of Common Stock.  Alec L. Poitevint,  II has sole voting
and dispositive power with respect to 408,844 of the shares of Common Stock; and
may be deemed to have  shared  voting  power with  respect to  3,750,324  of the
shares of Common  Stock  (constituting  37.3% of the total  voting  power of the
Common Stock) as a result of the Stockholders' Agreement.

Robert E. Hormann:

         In  accordance   with  Rule   13d-5(b)(1)  of  the  General  Rules  and
Regulations  under the Act, Robert E. Hormann may be deemed to beneficially  own
3,750,324 shares of Common Stock, which constitutes  approximately  37.3% of the
outstanding  shares of Common  Stock.  Robert E.  Hormann  has sole  voting  and
dispositive power with respect to 228,427 of the shares of Common Stock; and may
be deemed to have shared voting power with respect to 3,750,324 of the shares of
Common Stock  (constituting 37.3% of the total voting power of the Common Stock)
as a result of the Stockholders' Agreement.

Robert J. Elfanbaum:

         In  accordance   with  Rule   13d-5(b)(1)  of  the  General  Rules  and
Regulations under the Act, Robert J. Elfanbaum may be deemed to beneficially own
3,750,324 shares of Common Stock, which constitutes  approximately  37.3% of the
outstanding  shares of Common  Stock.  Robert J.  Elfanbaum  has sole voting and
dispositive power with respect to 102,375 of the shares of Common Stock; and may
be deemed to have shared voting power with respect to 3,750,324 of the shares of
Common Stock  (constituting 37.3% of the total voting power of the Common Stock)
as a result of the Stockholders' Agreement.


ITEM 6.  CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH
RESPECT TO SECURITIES OF THE ISSUER.

         See Item 4 above.




                                                Page 12 of 15 Pages

<PAGE>



ITEM 7.  MATERIAL TO BE FILED AS EXHIBITS.

         Appendix A - Shareholders' Agreement

         Exhibit 99.1 - Joint Filing Agreement

                                                Page 13 of 15 Pages

<PAGE>




                                   Signatures

         After  reasonable  inquiry and to the best of his knowledge and belief,
each of the  undersigned  certifies  that  the  information  set  forth  in this
Statement is true, complete and correct.

Date:  February 18, 1999


                                               DURVET/PMR, L.P.,
                                               By:  DURVET, INC.

                                               by:   /s/ Robert E. Hormann 
                                                     Name:  Robert E. Hormann
                                                     Title: President

                                               /s/ W. M.Jones, Jr.      
                                               W. M. Jones, Jr.

                                               /s/ Bruce G. Baker      
                                               Bruce G. Baker

                                               /s/ Robert W. Schlutz     
                                               Robert W. Schlutz

                                               /s/ Alec L. Poitevint, II    
                                               Alec L. Poitevint, II

                                               /s/ Robert E. Hormann      
                                               Robert E. Hormann

                                               /s/ Robert J. Elfanbaum     
                                               Robert J. Elfanbaum

                                                Page 14 of 15 Pages

<PAGE>



                                 SCHEDULE I


                       Executive Officers and Directors of
                                  Durvet, Inc.


Name                                          Business Address

Robert E. Hormann                             P.O. Box 279
President and Director                        100 S.E. Magellan Drive
                                              Blue Springs, Missouri  64014

John Harney                                   Nelson Wholesale
Chairman of the Board                         P.O. Box 370
                                              2400 Highway 377 South
                                              Brownwood, Texas  76801

Doug Gerdon                                   DuBoes Dest.
Director                                      P.O. Box 28
                                              1304 North Main
                                              Huntingburg, Indiana 47542

Kevin Lynch                                   Animal Health Sales, Inc.
Director                                      P.O. Box 330
                                              #44 Route 113
                                              Selbyville, Delaware 19975

John Scheuber                                 Veterinary Service, Inc.
Director                                      P.O. Box 538
                                              Salida, California  95368


                                                Page 15 of 15 Pages

<PAGE>

                                                             Appendix A

                        STOCKHOLDERS' AGREEMENT

         This Agreement dated as of February 8, 1999 by and between Virbac S.A.,
a French  corporation  ("VBSA"),  and the stockholders of  Agri-Nutrition  Group
Limited who have  executed this  agreement  (the "AGNU  Stockholders"  with each
being referred to herein as a "Stockholder").

         WHEREAS,  Agri-Nutrition  Group Limited  ("AGNU") has entered into that
Agreement and Plan of Merger with VBSA and Virbac,  Inc., a Delaware corporation
and subsidiary of VBSA  ("Virbac"),  dated as of October 16, 1998, as amended by
the First  Amendment  to  Agreement  and Plan of Merger,  dated as of November ,
1998,  among  AGNU,  VBSA and Virbac  (the  "Merger  Agreement"),  which  Merger
Agreement  sets forth the terms and  conditions of the merger of Virbac with and
into AGNU (the "Merger");

         WHEREAS,  each of the  Stockholders  beneficially  owns the  number  of
shares set forth  opposite  his or her name on  Exhibit A to this  Stockholders'
Agreement.  The shares of AGNU Common Stock described in the preceding  sentence
together  with any  other  voting  or  equity  securities  of AGNU of which  the
Stockholders  acquire beneficial  ownership after the date of this Stockholders'
Agreement  but prior to the  consummation  of the Merger are  referred to herein
collectively  as the "Shares."  Each  Stockholder is entitled to vote the Shares
beneficially  owned by the Stockholder,  and no Stockholder has entered into any
voting  arrangement  with  respect  to the  Shares  except as  provided  in this
Stockholders' Agreement or granted any proxy with respect to any of the Shares;

         WHEREAS,  in  connection  with  the  Merger  Agreement,   each  of  the
Stockholders  is  willing  to  agree,  to (i)  vote  the  Shares  owned  by such
Stockholder  for the  adoption of the Merger  Agreement  and the approval of the
Merger and the other  transactions  contemplated by the Merger Agreement subject
to the conditions set forth herein,  and (ii) the other matters  provided for in
this Stockholders' Agreement, upon the terms and conditions set forth herein;

         WHEREAS, pursuant to Section 8.1 of the Merger Agreement, the surviving
corporation in the Merger (the "Surviving  Corporation")  has agreed to make and
complete a tender  offer (the  "Tender  Offer") to  repurchase  1,000,000 of the
issued and  outstanding  shares of AGNU Common  Stock,  par value $.01 per share
("Common Stock"), at a price of $3.00 per share;

         WHEREAS,  upon  consummation  of the Merger and the Tender Offer,  VBSA
will indirectly own 60% of the outstanding  shares of AGNU Common Stock and VBSA
desires  assurance  that at least  1,000,000  shares  of AGNU  Common  Stock are
tendered in the Tender Offer; and

         WHEREAS,  the AGNU  Stockholders are willing in the event that at least
1,000,000  shares of AGNU Common Stock are not tendered by the  Stockholders  of
AGNU  in the  Tender  Offer  to  provide  sufficient  shares  to  the  Surviving
Corporation so that the entire 1,000,000 shares shall have been tendered.

         NOW,  THEREFORE,  in  consideration  of  the  premises  and  agreements
contained  in  this   Stockholders'   Agreement,   and  for  good  and  valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties, intending to be legally bound, hereby agree as follows:


<PAGE>



         1.  Defined  Terms.   Capitalized  terms  used  in  this  Stockholders'
Agreement will, unless otherwise defined in this Stockholders'  Agreement,  have
the meanings assigned to them in the Merger Agreement.

         2.       Voting Agreement.

         (a) AGNU Stockholders  Meeting.  Subject to Section 2(c) hereof, at the
AGNU  Stockholders  Meeting or any meeting of the stockholders of AGNU,  however
called,  and in any action by consent of the  stockholders  of AGNU, each of the
Stockholders will vote all of the Shares  beneficially owned by such Stockholder
and  entitled  to vote (i) for  approval of the Merger  Agreement  and the other
transactions  contemplated  by the Merger  Agreement,  (ii) for  approval of the
amendment to the AGNU Restated  Certificate of Incorporation  (the  "Certificate
Amendment")  to increase  the number of  authorized  shares of AGNU Common Stock
from  20,000,000  shares to  38,000,000  shares,  (iii)  against  any  action or
agreement  that  would  result  in a  breach  of any  representation,  warranty,
covenant,  agreement or other  obligation of AGNU under the Merger  Agreement or
may  result in any of the  conditions  to AGNU's  obligations  under the  Merger
Agreement not being fulfilled and (iv) in favor of any other matter necessary to
consummate the transactions  contemplated by the Merger Agreement and considered
and voted upon by the stockholders of AGNU.

         (b) Other  Actions.  Subject to Section 2(c) hereof,  the  Stockholders
will not solicit,  encourage or recommend to other  holders of AGNU Common Stock
that those  holders  (i) vote  their  shares of AGNU  Common  Stock or any other
securities of AGNU in any manner that would,  directly or indirectly,  impede or
adversely  effect  stockholder  approval of the Merger  Agreement  and the other
transactions  contemplated by the Merger Agreement or the Certificate Amendment,
(ii) at the AGNU Stockholders Meeting, abstain from voting, or otherwise fail to
vote,  their  shares of AGNU  Common  Stock,  (iii)  sell,  transfer,  tender or
otherwise  dispose of their  shares of AGNU Common  Stock or (iv)  exercise  any
dissenters' appraisal or other similar rights, if any.

         (c) Limitation on Obligations.  The obligations under Sections 2(a) and
2(b) of each Stockholder who is a director of officer of AGNU are subject to his
obligation  to  faithfully  discharge  his duties as a director or an officer of
AGNU;  provided,  however,  if AGNU  has not  terminated  the  Merger  Agreement
pursuant  to  Section  10.1(g)  of the  Merger  Agreement  or if Virbac  has not
terminated  the  Merger  Agreement  pursuant  to  Section  10.1(f) of the Merger
Agreement,  each such  Stockholder  will  vote his  Shares  in  accordance  with
Sections 2(a) and 2(b).

         3.  Agreement  to Tender  Common  Stock.  In the event  that fewer than
1,000,000 shares of Common Stock are tendered by the stockholders of AGNU in the
Tender Offer, the AGNU Stockholders hereby agree that they will tender shares of
Common Stock equaling the  difference  between  1,000,000  shares and the amount
actually tendered.

         4.  Amount  of Common  Stock to be  Tendered.  In the  event  that five
business  days  prior  to the  expiration  date of the  Tender  Offer  the  AGNU
Stockholders  have not reached an agreement as to the number of shares that each
Stockholder  will tender to the  Surviving  Corporation,  then each  Stockholder
shall tender  his/its  shares on a pro rata basis in proportion to the amount of
shares held by each  Stockholder  on the  expiration  date of the Tender  Offer,
excluding any shares accepted for tender in the Tender Offer.


<PAGE>



         5. Share Ownership.  Each  Stockholder  represents and warrants to VBSA
that,  as of the date of this  Stockholders'  Agreement,  the  Shares  set forth
opposite such Stockholder's  name on Exhibit A to this  Stockholders'  Agreement
constitute  all of the shares of AGNU Common  Stock  beneficially  owned by such
stockholder and such Shares are owned free and clear of any Liens.

         6.  No  Other  Obligations  or  Liabilities.   The  execution  of  this
Stockholders'  Agreement  by the AGNU  Stockholders  will not have the effect of
creating any  obligations  or liabilities  other than those  expressly set forth
herein.

         7.       Miscellaneous.

         (a)  Counterparts.  This  Stockholders'  Agreement  may be executed and
delivered in one or more  counterparts,  and by the different  parties hereto in
separate counterparts,  each of which when executed and delivered will be deemed
to be an original but all of which taken  together  constitute  one and the same
agreement.

         (b)  Governing  Law. This  Stockholders'  Agreement is governed by, and
construed in accordance  with, the laws of the State of Delaware  without giving
effect to applicable principles of conflicts of law.

         (c) Entire  Agreement.  This  Stockholders'  Agreement  constitutes the
entire  agreement  of the  parties  and  supersedes  all  prior  agreements  and
undertakings,  both written and oral, between the parties,  or any of them, with
respect to the subject matter hereof.



<PAGE>


         IN WITNESS WHEREOF, the parties have duly executed this Agreement as of
the date first above written.

                                           VIRBAC, S.A.


                                             By:               
                                             Name:               
                                             Title:                  


                                             AGNU STOCKHOLDERS:

                                             Durvet/PMR, L.P.,

                                             By:Durvet, Inc. its general partner

                                             /s/ Robert E. Hormann  
                                             Name:  Robert E. Hormann
                                             Title:  President


                                             /s/ W. J. Jones, Jr.    
                                             W.M. Jones, Jr.


                                             /s/ Bruce G. Baker        
                                             Bruce G. Baker


                                             /s/ Robert W. Schlutz   
                                             Robert W. Schlutz


                                             /s/ Alec E. Poitevint, II   
                                             Alec. E. Poitevint, II


                                             /s/ Robert E. Hormann     
                                             Robert E. Hormann


                                             /s/ Robert J. Elfanbaum     
                                             Robert J. Elfanbaum









                                                                   Exhibit 99.1

                            JOINT FILING AGREEMENT

In accordance  with Rule  13d-1(f)(1) of Regulation 13D of the General Rules and
Regulations of the Securities and Exchange  Commission  under the Securities Act
of 1934, as amended, the undersigned agree to the joint filing on behalf of each
of them of this statement and any amendments hereto.

Date:  February 18, 1999



                                    DURVET/PMR, L.P.,
                                    By:  DURVET, INC.

                                    by:   /s/ Robert E. Hormann                 
                                          Name:  Robert E. Hormann
                                          Title: President

                                    /s/ W. M.Jones, Jr.                         
                                    W. M. Jones, Jr.

                                    /s/ Bruce G. Baker                          
                                    Bruce G. Baker

                                    /s/ Robert W. Schlutz                       
                                    Robert W. Schlutz

                                    /s/ Alec L. Poitevint, II                   
                                    Alec L. Poitevint, II

                                    /s/ Robert E. Hormann                       
                                    Robert E. Hormann

                                    /s/ Robert J. Elfanbaum                     
                                    Robert J. Elfanbaum



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission